This study showed that laboratory markers of recent infection by dengue, Zika or chikungunya arboviruses were detected in the biological samples of approximately one-third of patients with ...

The Ministry of Health has noted that delays in hospital admission are contributing to the rise in dengue-related deaths ...

Bangladesh is simply unable to handle the convergence of infectious diseases, such as COVID-19, dengue, and chikungunya, due to poor public awareness, as well as inadequate testing and treatment ...

Kennedy Jr. in the country's top health position, use of a long-approved vaccine against measles, mumps, rubella, and ...

In Brazil, researchers from the University of São Paulo (USP), the University of Brasília (UnB), and two startups in the city ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

COPENHAGEN, Denmark, June 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that it has entered into an agreement to sell its Priority Review Voucher (PRV) for a total cash consideration of ...

Europe is increasingly grappling with illness and deaths from extreme weather and the arrival of tropical diseases, but it ...

Among the deal’s top prospects is a Phase 3 vaccine candidate for the mosquito-borne chikungunya virus that showed promise in data published last month. For Chaplin, the vaccine represents the next ...

While public concern is rising over the worsening situation, the Janatha Vimukthi Peramuna/National People’s Power (JVP/NPP) ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...

Bavarian Nordic has commenced a Phase III trial of its chikungunya vaccine, CHIKV VLP, targeting the paediatric population ...